Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

VEGF antagonist distinguishes between pathological and appropriate retinal revascularization

May 7, 2002

Long-acting prophylactic efficacy demonstrated for ISV-401 in rabbit keratitis model

May 7, 2002

Anecortave stabilizes or improves vision in AMD according to preliminary phase II results

May 7, 2002

New data on the use of thymosin beta4 in the treatment of eye wounds

May 2, 2002

Intravitreal 2-methoxyestradiol implants effective in rat model of CNV

May 2, 2002

Lumigan approved by European Commission, introduced in three countries

April 29, 2002

Regulatory approval sought in Japan for Visudyne in AMD

April 24, 2002

Xalatan approved in E.U. as first-line therapy for lowering IOP in glaucoma patients

April 24, 2002

ISTA to proceed with Vitrase NDA filing

April 12, 2002

Third phase III trial under way for INS-365 Ophthalmic in dry eye

April 9, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.